‘Concerningly Low’ Use of CVD Meds for Secondary Prevention

This post was originally published on Medscape

You will shortly be re-directed to the publisher's website

Data from 17 countries show many patients with coronary artery disease or stroke do not receive medication for secondary prevention.
Medscape Medical News